Cargando…

Primary hyperoxaluria detected by bone marrow biopsy: case report

BACKGROUND: Primary hyperoxaluria is a rare disease with an estimated prevalence of 1 to 3 cases per million. It is due to a hepatic enzyme deficiency responsible for an endogenous overproduction of oxalate. Oxalate crystals commonly deposit in the kidney and more rarely in bone marrow. The literatu...

Descripción completa

Detalles Bibliográficos
Autores principales: Nachite, F., Dref, M., Fakhri, A., Rais, H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5607598/
https://www.ncbi.nlm.nih.gov/pubmed/28943803
http://dx.doi.org/10.1186/s12907-017-0059-7
_version_ 1783265320027291648
author Nachite, F.
Dref, M.
Fakhri, A.
Rais, H.
author_facet Nachite, F.
Dref, M.
Fakhri, A.
Rais, H.
author_sort Nachite, F.
collection PubMed
description BACKGROUND: Primary hyperoxaluria is a rare disease with an estimated prevalence of 1 to 3 cases per million. It is due to a hepatic enzyme deficiency responsible for an endogenous overproduction of oxalate. Oxalate crystals commonly deposit in the kidney and more rarely in bone marrow. The literature has reported, to the best of our knowledge, only two cases of hyperoxaluria diagnosed by bone marrow biopsy and our case is the only one that does not show radiological bone lesions. CASE PRESENTATION: A young 22 year old chronic hemodialysis patient with nephrocalcinosis. The patient had a personal and family history of recurrent kidney stones. He presented bone pain with worsening of his general state. On physical examination, no organomegaly was detected. Biological check-up showed only a normochromic and normocytic regenerative anemia resistant to treatment and a bone marrow biopsy was performed. It showed deposits of crystals of oxalate in the bone marrow surrounded by inflammatory reaction against foreign bodies. Given our context, no liver biopsy or genetic studies, which are gold standard of diagnosis testing, were done. The diagnosis of primary hyperoxaluria was made based on morphological characteristics of crystals, his medical and family history, and the absence of any secondary cause of the condition. Since curative treatment is not available in our country, the patient only receives a palliative treatment. CONCLUSION: Primary hyperoxaluria is rarely evoked by the histological study of a bone marrow biopsy. The lack of the possibility of the only effective treatment in our context and the diagnosis, usually late, of this pathology are at the origin of the fatal evolution of the disease in almost all the cases.
format Online
Article
Text
id pubmed-5607598
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-56075982017-09-24 Primary hyperoxaluria detected by bone marrow biopsy: case report Nachite, F. Dref, M. Fakhri, A. Rais, H. BMC Clin Pathol Case Report BACKGROUND: Primary hyperoxaluria is a rare disease with an estimated prevalence of 1 to 3 cases per million. It is due to a hepatic enzyme deficiency responsible for an endogenous overproduction of oxalate. Oxalate crystals commonly deposit in the kidney and more rarely in bone marrow. The literature has reported, to the best of our knowledge, only two cases of hyperoxaluria diagnosed by bone marrow biopsy and our case is the only one that does not show radiological bone lesions. CASE PRESENTATION: A young 22 year old chronic hemodialysis patient with nephrocalcinosis. The patient had a personal and family history of recurrent kidney stones. He presented bone pain with worsening of his general state. On physical examination, no organomegaly was detected. Biological check-up showed only a normochromic and normocytic regenerative anemia resistant to treatment and a bone marrow biopsy was performed. It showed deposits of crystals of oxalate in the bone marrow surrounded by inflammatory reaction against foreign bodies. Given our context, no liver biopsy or genetic studies, which are gold standard of diagnosis testing, were done. The diagnosis of primary hyperoxaluria was made based on morphological characteristics of crystals, his medical and family history, and the absence of any secondary cause of the condition. Since curative treatment is not available in our country, the patient only receives a palliative treatment. CONCLUSION: Primary hyperoxaluria is rarely evoked by the histological study of a bone marrow biopsy. The lack of the possibility of the only effective treatment in our context and the diagnosis, usually late, of this pathology are at the origin of the fatal evolution of the disease in almost all the cases. BioMed Central 2017-09-20 /pmc/articles/PMC5607598/ /pubmed/28943803 http://dx.doi.org/10.1186/s12907-017-0059-7 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Case Report
Nachite, F.
Dref, M.
Fakhri, A.
Rais, H.
Primary hyperoxaluria detected by bone marrow biopsy: case report
title Primary hyperoxaluria detected by bone marrow biopsy: case report
title_full Primary hyperoxaluria detected by bone marrow biopsy: case report
title_fullStr Primary hyperoxaluria detected by bone marrow biopsy: case report
title_full_unstemmed Primary hyperoxaluria detected by bone marrow biopsy: case report
title_short Primary hyperoxaluria detected by bone marrow biopsy: case report
title_sort primary hyperoxaluria detected by bone marrow biopsy: case report
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5607598/
https://www.ncbi.nlm.nih.gov/pubmed/28943803
http://dx.doi.org/10.1186/s12907-017-0059-7
work_keys_str_mv AT nachitef primaryhyperoxaluriadetectedbybonemarrowbiopsycasereport
AT drefm primaryhyperoxaluriadetectedbybonemarrowbiopsycasereport
AT fakhria primaryhyperoxaluriadetectedbybonemarrowbiopsycasereport
AT raish primaryhyperoxaluriadetectedbybonemarrowbiopsycasereport